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Objective: To gain insight into the standards of rationality that physicians use when evaluating patients’
treatment refusals.
Design of the study: Qualitative design with indepth interviews.
Participants: The study sample included 30 patients with cancer and 16 physicians (oncologists and
general practitioners). All patients had refused a recommended oncological treatment.
Results: Patients base their treatment refusals mainly on personal values and/or experience. Physicians
mainly emphasise the medical perspective when evaluating patients’ treatment refusals. From a medical
perspective, a patient’s treatment refusal based on personal values and experience is generally evaluated
as irrational and difficult to accept, especially when it concerns a curative treatment. Physicians have a
different attitude towards non-curative treatments and have less difficulty accepting a patient’s refusal of
these treatments. Thus, an important factor in the physician’s evaluation of a treatment refusal is whether
the treatment refused is curative or non-curative.
Conclusion: Physicians mainly use goal oriented and patients mainly value oriented rationality, but in the
case of non-curative treatment refusal, physicians give more emphasis to value oriented rationality. A
consensus between the value oriented approaches of patient and physician may then emerge, leading to
the patient’s decision being understood and accepted by the physician. The physician’s acceptance is
crucial to his or her attitude towards the patient. It contributes to the patient’s feeling free to decide, and
being understood and respected, and thus to a better physician–patient relationship.
W
hen a patient decides to refuse a recommended
oncological treatment, the physician is faced with
questions about the background of this decision, the
patient’s arguments, the acceptability of the decision, and the
patient’s role in the decision making process. The physician
has to evaluate the patient’s decision: Is it sensible,
responsible, and judicious? Often the evaluation is then
directed to the question: Is the patient’s decision rational or
not?1 2 The actual standards of rationality in these cases,
however, are not clear. The question therefore arises: On
what basis do physicians distinguish between their patients’
rational and irrational arguments?
In medical ethical literature, rationality is described in
various ways. Rational choice has—for example, been des-
cribed as the choice that maximises expected utility or that
satisfies the patient’s aims and values most.1 In other cases,
having ‘‘good reasons’’ is at the centre of the evaluation
of rationality.2–4 Savulescu and Momeyer state that ‘‘It is
rational for a person to perform some act if there would be a
good reason to perform that act if the facts were as he/she
believes them to be.’’2 A pilot study revealed that a phy-
sician’s evaluation of the rationality of the patient’s decision
is crucial to their attitude towards the patient: if a physician
thinks the patient’s refusal is not based on good reasons, he
or she is often inclined to consider the decision as irrational
and will keep trying to convince the patient to accept the
treatment.4 The evaluation of ‘‘good reasons’’, however, raises
another question: What makes a reason a good reason—
‘‘good’’ in a medical context, ‘‘good’’ in a patient context, or
‘‘good’’ in both?
The purpose of this article is to gain insight into the
standards of rationality used by physicians. We focus on two
aspects of this issue. Firstly, we describe what is meant in
daily medical practice by rational decision making and
discuss what physicians understand by ‘‘good reasons’’ to
refuse recommended oncological treatment. Secondly, we
discuss what motivates a patient to refuse a treatment and
how this is communicated to their physician.
METHODS
The present study is based on indepth interviews with
patients and physicians. All patients had refused a recom-
mended oncological treatment. In this study refusal meant
the patient did not start treatment at all; or stopped during
treatment; or refused a part of a recommended treatment but
accepted another (for example, accepted surgery but refused
chemotherapy). A qualitative research method was adopted
to explore patients’ deliberations that led to refusal of a
recommended oncological treatment and to determine
physicians’ evaluations of the treatment refusals. The study
was approved by the medical ethics committees at the study
sites. All patients gave written informed consent.
Participants
Patients who have refused an oncological treatment are
difficult to enrol for a research sample.4 One reason may be
that after their refusal, they have withdrawn from the
medical circuit and are therefore not easy to approach.
Another reason may be that after their withdrawal, patients
no longer want to be involved in medical research, either
because they do not want to be confronted by hospitals or
doctors again or because they are too ill to be interviewed.
The patients included in this study form a rather unique
sample and deserve our gratitude.
A total of 30 patients (mean age 58 years, range 23–91)
were interviewed. The inclusion criteria were: (a) age more
than 18 years; (b) able to speak and understand Dutch: (c)
having cancer; (d) life expectancy of more than three
months; and (e) having refused a recommended oncological
treatment. The patients were asked to participate by general
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practitioners (n=5) and by specialists in a university
hospital (n=6) or in general hospitals (n=2) in the
Netherlands. Dutch associations for patients with cancer
were willing to spread information about the study. Patient
members of these associations (n=17) responded them-
selves to the call to participate. All patients recruited by the
physicians or those who responded themselves between
January 2001 and April 2002 were included in the study if
they met the inclusion criteria. We included both patients
who had refused a recommended treatment with higher
potential benefit (curative treatment, n=10) and patients
who had refused a recommended treatment with lower
potential benefit (non-curative treatment, n=20).
Demographic and clinical characteristics of the patients are
given in table 1.
A total of 16 physicians were interviewed from among the
physicians who recruited the patients. Eight general practi-
tioners (50%) and eight (general) oncologists (50%) were
selected, including younger and older (mean age 49 years,
range 29–60), male (n=11, 69%) and female (n=5, 31%)
physicians with few to many years of working experience
(mean 18 years, range 2–29), and from different settings
(general practice, university hospital, and general hospital).
The interviews were carried out between May and October
2002.
Interview procedure
Each patient interview was carried out at the patient’s home
and lasted between 60 and 120 minutes. We used indepth
interview techniques—that is, the interviews contained some
general topics and no close ended questions.5 The interview
topics covered demographic and clinical characteristics of the
patient; the course of the disease; communication with
physicians about the recommended treatment; the patient’s
attitude to the recommended treatment; and the patient’s
perspectives of the future. The interview topics were for-
mulated after examining the relevant literature and under-
taking preliminary observational studies. In these studies, 72
patients were observed during their visits to five different
oncologists at an oncological outpatient clinic in the
Netherlands. From the transcripts, various aspects of the
discussions between physicians and patients about recom-
mendations for treatment were noted and converted into
interview topics.
Each physician was interviewed at their office. The
interview lasted between 30 and 60 minutes. The indepth
interview topics covered the characteristics of the physician;
working experience; curative versus non-curative treatment
and palliative care in oncology; the physician–patient
relationship, especially concerning treatment decisions;
patient autonomy; physician’s beneficence; and treatment
refusals and their rationality. At the end of the interview, the
medical history of one patient who participated in the study
was presented as a case (see box 1), and the physicians
were asked to give their opinion about the rationality of the
patient’s decision.
Analysis
All the patient and physician interviews were audiotaped
and transcribed. A descriptive qualitative approach was used
to analyse the interviews.6 During the analysis, we used
computer software (Kwalitan 5.0; VAM Peters, Radboud
University, Nijmegen) for multiple text management, includ-
ing coding, locating, and retrieving key materials, phrases,
and words. Each interview was divided into several segments.
The segments were coded and the codes were organised into
categories and put into a tree structure. A second indepen-
dent researcher supervised the process of data management.
RESULTS
The medical perspective
Mrs S’s case (see box 1) was presented to all the physicians in
the study. They were asked whether they would judge her
decision as rational or as irrational.
Physician 1: If it is related to previous communication
breakdown combined with an enormous amount of fear
thus preventing the patient from forming a good idea of
what that cancer can do if it is not treated, and no good
decisions are made, then I find it irrational. Or at least
something I would try to change.
Table 1 Demographic and clinical characteristics of the
patients included in the present study (n = 30). Values are
n (%)
Sex
Men 12 (40)
Women 18 (60)
Marital status
Single/divorced, widowed 13 (43)
Married/registered partnership 17 (57)
Education
Primary school/lower level secondary school 9 (30)
Middle level secondary school 6 (20)
Advanced professional/university 15 (50)
Cancer diagnosis
Breast 11 (37)
Gastroenterological 8 (27)
Urological 3 (10)
Gynaecological 2 (7)
Pulmonary 2 (7)
Haematological 2 (7)
Other 2 (7)
Box 1: The case of Mrs S
Mrs S is 54 years old. After a period of fever and
pneumonia, she was diagnosed as having bronchial
carcinoma (non-small cell lung cancer in the upper right
pulmonary lobe). The attending physician recommended
surgery in which part of the lung would be removed
(lobectomy). Mrs S decided to refuse the recommended
surgery.
Mrs S: ‘‘I was afraid, and this fear was based on the
mediastinoscopy [a diagnostic procedure carried out behind
the sternum in the upper part of the chest cavity, which she
recently had undergone; TvK]. I awoke when I was still in the
operating room. I think something was not timed very well. A
tube was still in my throat. I don’t know if the tube was in my
trachea or in my throat. I don’t know, but I heard someone
say that the surgery had been successful. And I was choking,
I pulled out the tube and immediately afterwards I was
transferred to the recovery room and there, for one and a
half hours, I had terrible shortness of breath. I really thought I
would suffocate.’’
‘‘At that moment I thought: What if I had to undergo such a
lobectomy? Then I would be in intensive care for three or four
days. What if I keep getting that suffocating feeling. I know
that they may make it technically possible for me not to really
suffocate, but the feeling is terrible. I took three days to reflect
on that, and then I decided for myself, no surgery. I am
afraid. It is fear, fear of the surgery, and what may come
afterwards.’’
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Physician 2: Well, those experiences, if they are based
somehow on facts that I can verify, I could find that
rational. But when I have the feeling that it is not based on
facts, I find it very irrational.
The physician interviews revealed that physicians mainly
emphasise the medical perspective when evaluating what are
good reasons, and thus, what is rational. This perspective
consists of a system of terminologies, deliberations, and
expressions that are common in medical practice. The
physicians indicated that if a patient’s refusal was based on
reasons related to the kind of tumour, the prognosis, and/or
the side effects of the treatment, they were rather inclined to
evaluate these reasons as good reasons and to accept the
refusal. Moreover, the physicians felt that rational arguments
are related to those reasons that are scientifically proved,
such as the chance of the treatment being effective or gaining
medical benefit. If a patient refuses oncological treatment
because he or she does not want to experience the side
effects, a physician judges this decision to be rational if side
effects are indeed expected to occur.
Physician 3: If the chance of effectiveness is small and the
price one has to pay is high with regard to side effects, I
can imagine someone saying: ‘‘It is not worth all the
trouble and at this moment I have few complaints, thus
why should I?’’. I find that a rational argument.
A significant factor in the physician’s evaluation of a
patient’s decision is the phase of the patient’s disease; the
distinction between the curative and palliative phases of the
disease and treatment processes plays an important role in a
physician’s evaluation and acceptance of a patient’s refusal
for treatment.
Physician 4: Well, if patients could just really realise what
they may be missing, with the treatment they could get if
they continue, if they at least know that. Then I could
accept it [treatment refusal]. And I’m talking particularly
about palliative treatment. As for a cure, I would always
be willing to go a bit further and possibly involve some
colleagues.
Curative treatment
The interviews revealed that when a physician thinks there is
a reasonable chance of cure, a patient’s treatment refusal is
often judged as irrational and is difficult to accept for the
physician. Physicians evaluate the decision to accept or to
refuse a recommended oncological treatment as a decision
about life or death: when the patient refuses treatment, he or
she chooses for disease progression, with a greater chance of
dying from the disease. They consider the decision to refuse
curative oncological treatment out of proportion. From a
physician’s point of view, the consequences of the decision
are enormous and cannot be compared with the possible side
effects of the treatment. In other words, according to the
physician, the benefits of being treated are much greater than
the price the patient has to pay.
Physician 4: Those tubes [of Mrs S], I do not find that
rational. It is not such a big problem compared to the fact
that she can remain alive. The patient does not see the
right relation between the proportions [sic]. It’s like when
you say that your cat will be alone for one day—that has
no relation to what you can gain from it [treatment].’’
Age also seems to play a role in the physician’s evaluation
of a patient’s refusal of curative treatment. Physicians find it
easier to accept a treatment refusal by an older than a
younger patient.
Physician 5: Concerning chemotherapy, which can also
cure the elderly, I can imagine some people would not
want that. I would agree to not giving chemotherapy with
a curative intention. Concerning young people, I find it
hard not to offer curative treatment, because that is simply
choosing death. In such cases I am the attending physician
who will try to win someone over.
Non-curative treatment
When a physician is of the opinion that cure is no longer an
option, the decision of a patient to refuse oncological
treatment seems easier to accept compared with the situa-
tion in which there is a reasonable chance of cure. The
appropriateness of the decision about non-curative oncologi-
cal treatment directed at palliation, which includes choices
about prolonging life as well as quality of life, is perceived
differently from the decision about curative oncological
treatment. The consequence of refusing non-curative onco-
logical treatment may be that the patient will die a few
months earlier, but it is not a matter of life or death.
Physicians are of the opinion that in the palliative phase the
most important thing is accurate interpretation of the
patient’s wishes, and in these circimstances it is the patient
who decides what a ‘‘good’’ palliative phase actually means.
The interviews revealed that physicians find the degree of
rationality of patients’ arguments less important from a
medical perspective when it comes to decisions about non-
curative treatment compared with decisions about curative
treatment: in the palliative phase, the best option for the
patient is at the forefront, and this option does not have to be
in agreement with the best medical option.
Physician 4: And when that patient just says, ‘‘Well, for
me it is not a matter of a long life, I just want a good
quality of life and I just want to do some nice things’’,
yeah, I find that a very good reason.
Life expectancy seems to play an important role in the
physician’s evaluation and acceptance of a patient’s refusal of
non-curative treatment. For example, patients with breast
cancer can receive non-curative treatment for a very long
time. A patient with a prognosis of a five year palliative
phase, could, by her decision to refuse treatment, shorten
her life by several years. That decision is much more difficult
for a physician to accept compared with a decision about a
palliative phase lasting only a few months. In the latter case,
refusing oncological treatment could mean that instead of,
for instance, six months, the patient’s prognosis would be
three months.
Physician 6: For some treatments, like for metastasised
stomach carcinoma, you wonder whether or not you
should carry it [treatment] out. And if patients say, ‘‘I don’t
want it’’, I will not say they have to. Regarding breast
cancer, I am more inclined to convince patients of the
usefulness of the treatment, because there are some very
valuable palliative treatments. … The tumours respond
very well and very good palliative effect can be attained.
As such, the patient’s complaints disappear and they will
benefit from the treatment for a long time. … Concerning
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breast cancer you will try to convince patients, whereas in
stomach cancer you will try but to a lesser degree.
As with refusal of curative treatment, age also seems to
play a role in the physician’s evaluation of a patient’s decision
to refuse non-curative treatment, mostly in combination with
life expectancy. When it is expected that a recommended
treatment will prolong a patient’s life by several years, the
decision of a younger patient to refuse treatment is more
difficult to accept than when an older patient makes the
same decision. If the aim of the recommended non-curative
oncological treatment is to prolong life by several months, the
age of the patient—that is, whether the decision to refuse is
made by a younger or an older patient—usually does not
make a difference to the physician’s acceptance of the
decision.
To illustrate this point, Mrs S’s case can be used again as an
example. As revealed by our empirical study, if Mrs S’s
decision concerned curative treatment, physicians would find
it very hard to accept it: the decision is irrational from a
medical point of view since it is very unlikely that she would
have the same experience again. If the decision concerned
non-curative treatment, physicians would find it easier to
accept it, even though Mrs S’s life expectancy can be
prolonged by the treatment. In the latter case, the physician
is inclined to place more emphasis on the patient’s con-
siderations about fear, experiences, and personal wishes and
desires than on whether their arguments are rational or
irrational from a medical perspective.
Physician 1: It is irrational, but for her [Mrs S] it is reality.
Physician 7: Why she [Mrs S] does it is irrational, but the
decision is easy to sympathise with, that’s the problem.
From the last quote, it appears that a physician may
sometimes experience problems when evaluating the
patient’s decision. The physician may judge the patient’s
treatment refusal as irrational since the decision, from a
medical point of view, is not based on good reasons. The
decision is based on emotions and on arguments that result
from a false impression of things—that is, from earlier
experiences of the patient that are not likely to occur a second
time. At the same time, however, the same physician may—
from a patients’ perspective—sympathise with the decision.
The patient’s perspective
The reasons why patients refuse oncological treatment are
diverse (table 2).
Both medical and personal considerations seem to play a
role in the patient’s decision to refuse treatment, but personal
values and experiences predominate. For example, patients
may find it important to occupy themselves—painting,
playing tennis, or walking in the mountains. If the side
effects of chemotherapy would prevent them from carrying
out these activities, the patients in the present study
indicated that the meaning of their life would be gone and
quality of life decreased. Our empirical study revealed that
patients find quality of life to be very important. It was clear
that many patients believed that quality of life was
incompatible with receiving oncological treatment. More
than half chose not to be treated because they believed that
treatment would not result in a better quality of life and
would only cause side effects and/or increase or induce
symptoms. Some patients indicated they would rather live for
a little lesser time than prolong their lives with all kinds of
troubles due to treatment.
Patient 1: my quality of life will diminish when you remove
a large part of the small intestine.
Patient 2: nevertheless have a fine life, higher quality of
life, without chemotherapy.
Patient 3: that I risked suffering side effects from the
‘‘pleasant’’ radiotherapy that actually would diminish my
quality of life scared me stiff.
Patient 4: we can postpone death with chemotherapy. But
then, in this period of postponement, how will I live? What
will my quality of my life be like? Thus, I have to give up
quality.
For some patients with breast cancer, losing a breast plays
an important role in their decision to refuse surgery. Such a
decision is based on important considerations of the patient’s
life: keeping her breast may reflect personal values such as
identity, dignity, and/or integrity. The importance the patient
attaches to her personal values underlies her refusal for
treatment, and, apparently, her personal values are so
important that she uses them as an argument for a decision
that may have far-reaching consequences.
As also revealed in the case of Mrs S, patients’ personal
considerations that underlie a treatment refusal are often
based on earlier experiences or on stories and experiences of
others. The interviews revealed that most patients referred
to their own experience or that of others as a source of
knowledge as to what they can expect from being treated
or not. These experiences seem to highly inspire patients’
decision making.
Patient 5: Besides, two days before I went to my GP, I had
buried my friend who had been ill for six years. She had
undergone all the standard things and suffered horribly.
She was groaning with pain when I visited her at the
hospital and I found it just terrible. … Afterwards I buried
another friend who was also ill for six years. … I saw these
friends of mine. I saw them suffering. … And since I have
Table 2 Reasons why patients refuse a recommended
oncological treatment
Believe in the body’s own curative possibilities
Do not want a stoma
Do not want to be ill due to the treatment
Do not want to be used as a guinea pig
Do not want to enter into menopause, still wanting a child
Do not want to fight anymore
Do not want to lose a breast
Do not want to lose hair
Do not want to reach old age with dementia, incontinence, and
dependency
Do not want to spend valuable time in hospital
Have accepted death
Have a lot to cope with, want to take time to do that
Have already reached old age
Have fear of treatment
Have no trust in treatment/medical establishment
Resist chemotherapy; consider it poison
Treatment decreases quality of life
Treatment will not result in cure, is only life prolonging
Want to continue playing tennis, making paintings, or walking in the
mountains
Want to stay in control
Want to take responsibility for themselves
Want to work on the initial cause of the cancer, not just removing the
symptoms
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witnessed and seen all of that, I think well then perhaps just
let me go, but don’t torture me.
Much of the criticism by patients who refused treatment
is related to the fact that treatment is often offered as the
‘‘standard treatment’’, based on statistics. Our patients
indicated that they did not recognise themselves in these
statistics. Moreover, they found it important to be approa-
ched as individuals.
Patient 6: I think, you can say whatever you like, but of
course for them I am only a case. And they apply a lot of
statistics to it. ‘‘If we do that, this will happen and so many
will survive. If we don’t do that, so many will die.’’ I think,
that’s not how it works. I am an individual, I have my
history, I have all different kinds of perspective.
When offered treatment as the ‘‘standard treatment’’,
some patients feel they are not being given sufficient room to
reflect on the recommended treatment. Personal considera-
tions, based on norms and values to which they attach great
importance, are not allowed to play a role.
Patient 7: You have to get the chance, I think, as a human
being, to be allowed to reflect on it [treatment], to consider
what are the consequences and then only decide whether
or not you can or want to do it. At that time, that was
absolutely not the case. That was it, that was standard. …
But a patient with cancer is his own ‘‘hands-on’’ expert
and physicians have to pay much more attention to what
the patient himself experiences. They can learn a lot from
their patients, like trying not to say, ‘‘This is the European
standard, these things make up the treatment and that’s
what you have to do’’.
DISCUSSION AND CONCLUSION
Our study revealed that when patients decide to refuse a
recommended oncological treatment, the physician’s per-
spective may not concur with the patient’s perspective. Only
few studies have investigated the reasons why patients opt
for or against treatment. According to Fried et al, the burden
of treatment, the outcome, and the likelihood of the outcome
all influence patients’ treatment preferences.7 Slevin et al
described how patients make a cost–benefit assessment of
chemotherapy before opting for or against radical treatment.
Chance of a cure, prolonging life, and relief of symptoms
were weighed.8 Siminoff and Fetting investigated factors
affecting treatment decisions in the case of breast cancer.
They found that patients who did not accept their physician’s
treatment recommendation weighed the benefits of treat-
ment against the probability and severity of side effects.9
Studies examining the types of trade-off patients with early
breast cancer make between benefits and side effects reveal
that women with milder side effects (less toxicity) judged
smaller benefits worthwhile and that small improvements in
survival were sufficient to make adjuvant chemotherapy
worthwhile.10 11 In addition to weighing improvements in
survival and side effects, women with dependants and social
support judged smaller benefits worthwhile.10 Our results
show that a patient’s decision to refuse a recommended
oncological treatment is not particularly based on weighing
the pros and cons of treatment from a medical perspective.
The decision relies, in particular, on personal values and/or
experiences, which seem not to be based on a general moral
point of view but seem to have a circumstantial basis—that
is, the patient takes his or her own circumstances, at this very
moment, as a starting point.
From both the medical and the patient’s perspective, good
reasons can be given for refusing oncological treatment. The
two perspectives may overlap to some extent, but large parts
may not concur. Patients’ treatment decisions, which are
based on personal values or experiences, most of the time fall
outside a medical perspective and are judged by physicians as
irrational. The meaning and use of the term ‘‘rationality’’
from a medical perspective and from a patient’s perspective
can in our view be described by using the terms ‘‘goal
oriented rationality’’ (zweckrationalita¨t) and ‘‘value oriented
rationality’’ (wertrationalita¨t) as distinguished and defined by
Max Weber.12 Goal oriented rationality is directed at effects
considering a certain goal. It is part of instrumental
rationality; the effectiveness of the relation between means
and ends is most important. Value oriented rationality is not
directed at effects, but at a system of values. In our view, the
distinction between a medical perspective and a patient’s
perspective is based on physicians mainly using goal oriented
rationality. Physicians have means (medical treatment) to
reach a goal (cure the patient, prolong survival, or improve
the quality of life). They weigh the costs and benefits of
medical treatments, they opt for the best treatment, and they
want to use this treatment to help the patient. However,
physicians also seem to use value oriented rationality—for
example, a patient who refuses a medically advisable
treatment runs against the physician’s feeling of doing well.
Similarly, patients also seem to use goal oriented rationality
but to a lesser degree. They do consider advantages and side
effects of treatment, but concerning treatment refusal, they
mainly use a system of values—that is, they use value
oriented rationality. Thus, both seem to use value oriented as
well as goal oriented rationality but physicians put more
emphasis on the latter and patients on the former. Moreover,
physicians’ value oriented rationality is based on a general
moral point of view (for example, doing well), and patients’
value oriented rationality has a circumstanstial basis.
Nowadays, it is clearly established in medicine, ethics, and
law that a competent patient has the right to refuse medical
treatment. There is no difficulty if a patient’s refusal concurs
with the clinical evaluation, but the issue becomes proble-
matic when a patient’s refusal conflicts with medical
opinion.13 Physicians interpret decisions conflicting with
medical opinion mostly as irrational, and irrational decisions
are difficult to accept. When the patient expresses a non-
rational preference, physicians face a dilemma between their
duty to care for a patient and respect for patient autonomy—
that is, the personal choice of the patient. A physician may try
to convince their patient to agree with the doctor’s viewpoint
by discussing medical facts to ensure that the patient
understands his or her situation. Coercive methods to force
patients to agree, however, easily lead to miscommunication
and abandonment of the patient.
We argue that the issue is less problematic if physicians
interpret ‘‘good reasons’’ to refuse a recommended oncolo-
gical treatment from both the medical and the patient’s
perspective based on specific values. This already occurs in
the case of non-curative treatment. Physicians find it less
difficult to accept a patient’s refusal of a non-curative
treatment even if the refusal is, from a medical perspective,
based on irrational grounds. Then the physician seems to
place more emphasis on the patient’s value system. When a
physician attempts to see the patient’s perspective, this may
be enhanced by discussing the physician’s and patient’s
value-oriented rationalities in such a way that the circum-
stantial basis of the patient’s rationality is understood.
Respecting the patient’s perspective in the acceptance of
treatment refusal is important for the physician–patient
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relationship. The physician’s acceptance is crucial to his or
her attitude towards the patient: if a physician does not
accept the treatment refusal, he or she is often inclined to
persist in convincing the patient to accept the treatment.4
This results in patients experiencing that they are not really
free to make their decisions, leading to frustration and
miscommunication.14 If a physician does accept a patient’s
treatment refusal, this will contribute to the patient’s feelings
of being free to decide, to be understood and respected in his
or her decision, and thus contribute to a better physician–
patient relationship.
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